Two Sigma Investments’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,010
| Closed | -$21.3K | – | 3294 |
|
|
2023
Q4 | $21.3K | Sell |
2,010
-51
| -2% | -$541 | ﹤0.01% | 2962 |
|
|
2023
Q3 | $40.8K | Sell |
2,061
-717
| -26% | -$14.2K | ﹤0.01% | 2754 |
|
|
2023
Q2 | $213K | Sell |
2,778
-3,762
| -58% | -$288K | ﹤0.01% | 2549 |
|
|
2023
Q1 | $618K | Sell |
6,540
-4,372
| -40% | -$413K | ﹤0.01% | 2037 |
|
|
2022
Q4 | $1.06M | Buy |
10,912
+8,066
| +283% | +$785K | ﹤0.01% | 1611 |
|
|
2022
Q3 | $734K | Sell |
2,846
-226
| -7% | -$58.3K | ﹤0.01% | 1553 |
|
|
2022
Q2 | $571K | Sell |
3,072
-8,812
| -74% | -$1.64M | ﹤0.01% | 1716 |
|
|
2022
Q1 | $1.16M | Sell |
11,884
-5,651
| -32% | -$553K | ﹤0.01% | 1608 |
|
|
2021
Q4 | $2.87M | Buy |
17,535
+14,498
| +477% | +$2.37M | 0.01% | 1161 |
|
|
2021
Q3 | $829K | Sell |
3,037
-2,462
| -45% | -$672K | ﹤0.01% | 1780 |
|
|
2021
Q2 | $2.18M | Sell |
5,499
-971
| -15% | -$385K | ﹤0.01% | 1277 |
|
|
2021
Q1 | $3.49M | Buy |
6,470
+764
| +13% | +$413K | 0.01% | 1003 |
|
|
2020
Q4 | $2.16M | Buy |
5,706
+589
| +12% | +$223K | 0.01% | 1044 |
|
|
2020
Q3 | $1.93M | Buy |
5,117
+5,005
| +4,469% | +$1.89M | 0.01% | 920 |
|
|
2020
Q2 | $55K | Sell |
112
-2,870
| -96% | -$1.41M | ﹤0.01% | 1896 |
|
|
2020
Q1 | $1.1M | Buy |
2,982
+2,132
| +251% | +$784K | 0.01% | 909 |
|
|
2019
Q4 | $602K | Buy |
850
+145
| +21% | +$103K | ﹤0.01% | 1623 |
|
|
2019
Q3 | $453K | Buy |
+705
| New | +$453K | ﹤0.01% | 1496 |
|
|
2019
Q1 | – | Sell |
-756
| Closed | -$212K | – | 2441 |
|
|
2018
Q4 | $212K | Buy |
+756
| New | +$212K | ﹤0.01% | 1856 |
|
|
2015
Q3 | – | Sell |
-460
| Closed | -$827K | – | 2064 |
|
|
2015
Q2 | $827K | Sell |
460
-1,472
| -76% | -$2.65M | ﹤0.01% | 1506 |
|
|
2015
Q1 | $3.12M | Buy |
+1,932
| New | +$3.12M | 0.01% | 884 |
|
|
2014
Q2 | – | Sell |
-217
| Closed | -$149K | – | 2346 |
|
|
2014
Q1 | $149K | Buy |
+217
| New | +$149K | ﹤0.01% | 1845 |
|